Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene
- PMID: 7584077
Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene
Abstract
Human adeno-associated virus (AAV) integrates specifically into a site (AAVS1) on chromosome 19q13.3-qter. We report that both transfected and infected AAV-vectors will target a foreign gene preferentially to AAVS1. Of 11 infected cell lines studied, nine (82%) showed integration of the neomycin resistance marker into AAVS1, which confirms the findings of previous investigations. We also show site-specific integration (nine out of 12 cell lines, 75%) following transfection of an AAV vector containing the neomycin gene. The ability of transfected AAV sequences to preferentially target and express selectable genes at a known site in the human genome extends the potential use of AAV as a vector in gene therapy.
Similar articles
-
Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.J Hum Virol. 1999 Nov-Dec;2(6):359-68. J Hum Virol. 1999. PMID: 10774553
-
Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells.Virology. 2000 Mar 15;268(2):391-401. doi: 10.1006/viro.1999.0122. Virology. 2000. PMID: 10704347
-
Targeted integration of adeno-associated virus-derived plasmids in transfected human cells.Virology. 1998 Sep 30;249(2):249-59. doi: 10.1006/viro.1998.9332. Virology. 1998. PMID: 9791017
-
Parvovirus-based vectors for human gene therapy.Blood Cells. 1994;20(2-3):531-6; discussion 536-8. Blood Cells. 1994. PMID: 7538355 Review.
-
The use of recombinant adeno-associated virus for skeletal gene therapy.Orthod Craniofac Res. 2007 Feb;10(1):1-14. doi: 10.1111/j.1601-6343.2007.00381.x. Orthod Craniofac Res. 2007. PMID: 17284242 Review.
Cited by
-
Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination.J Virol. 2000 Nov;74(22):10631-8. doi: 10.1128/jvi.74.22.10631-10638.2000. J Virol. 2000. PMID: 11044107 Free PMC article.
-
Selective cleavage of AAVS1 substrates by the adeno-associated virus type 2 rep68 protein is dependent on topological and sequence constraints.J Virol. 2000 Oct;74(19):8831-42. doi: 10.1128/jvi.74.19.8831-8842.2000. J Virol. 2000. PMID: 10982325 Free PMC article.
-
Development of animal models for adeno-associated virus site-specific integration.J Virol. 1999 Mar;73(3):2517-26. doi: 10.1128/JVI.73.3.2517-2526.1999. J Virol. 1999. PMID: 9971837 Free PMC article.
-
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector.J Virol. 1998 Jun;72(6):5025-34. doi: 10.1128/JVI.72.6.5025-5034.1998. J Virol. 1998. PMID: 9573272 Free PMC article.
-
Stable secondary structure near the nicking site for adeno-associated virus type 2 Rep proteins on human chromosome 19.J Virol. 2005 Mar;79(6):3544-56. doi: 10.1128/JVI.79.6.3544-3556.2005. J Virol. 2005. PMID: 15731249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical